Yang Zi Wan Bao Wang·2025-09-29 08:58Group 1: Control Change Announcements - Multiple A-share companies, including Duori Pharmaceutical, Asia-Pacific Pharmaceutical, and Zhonghuan Environmental Protection, announced plans for control change on September 28 [1] - Duori Pharmaceutical's controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd., and actual controller Deng Yong are planning a change in control, leading to a suspension of trading from September 29, 2025, for up to two trading days [3] - Asia-Pacific Pharmaceutical received notification from its controlling shareholder, Ningbo Fubang Holdings Group Co., Ltd., regarding a potential change in control, with trading suspended from September 29, 2025, for up to two trading days [5] - Zhonghuan Environmental Protection's controlling shareholder, Zhang Bozhong, is also planning a control change, resulting in trading suspension from September 29, 2025, for up to two trading days [7] Group 2: Specific Company Details - Duori Pharmaceutical's stock was suspended at a price of 40.08, with a market capitalization of 3.206 billion [2] - Asia-Pacific Pharmaceutical's stock was suspended at a price of 5.67, with a market capitalization of 4.228 billion [4] - Zhonghuan Environmental Protection's stock was suspended at a price of 8.86, with a market capitalization of 3.761 billion [6]